Central Pacific Bank - Trust Division’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$209K Sell
2,417
-1
-0% -$88 0.02% 458
2026
Q2
$189K Buy
2,418
+168
+7% +$13.6K 0.02% 486
2026
Q1
$195K Sell
2,250
-50
-2% -$4.79K 0.02% 456
2025
Q4
$221K Hold
2,300
– – 0.03% 423
2025
Q3
$219K Hold
2,300
– – 0.03% 428
2025
Q2
$200K Hold
2,300
– – 0.03% 436
2025
Q1
$207K Sell
2,300
-200
-8% -$17.9K 0.03% 436
2024
Q4
$200K Buy
2,500
+89
+4% +$7.71K 0.03% 444
2024
Q3
$217K Buy
2,411
+311
+15% +$26.2K 0.03% 443
2024
Q2
$165K Hold
2,100
– – 0.02% 584
2024
Q1
$183K Buy
+2,100
New +$179K 0.02% 560

Other funds holding MDT

Central Pacific Bank - Trust Division's MDT Position: Q3 2026 in Review

Central Pacific Bank - Trust Division reduced its Medtronic (MDT) stake by 0.04% in Q3 2026, selling an estimated $88 and leaving 2,417 shares worth $209K. The position accounts for 0.02% of the portfolio, ranked #458.

Central Pacific Bank - Trust Division first reported a position in MDT in Q1 2024 and has held it in 11 quarters since. The position peaked at $221K in Q4 2025. 119 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Central Pacific Bank - Trust Division held 2,417 shares of Medtronic worth $209K as of Q3 2026.
  • Central Pacific Bank - Trust Division sold 1 Medtronic share in Q3 2026, an estimated $88.
  • Medtronic made up 0.02% of Central Pacific Bank - Trust Division's portfolio in Q3 2026, its #458 holding.
  • Central Pacific Bank - Trust Division first reported a position in Medtronic in Q1 2024 and has held it in 11 quarters since.
  • Central Pacific Bank - Trust Division's Medtronic position peaked at $221K in Q4 2025.
  • 119 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q3 2026, filed 6 Oct 2026.